Rights and permissions
About this article
Cite this article
Galantamine potentially cost saving for AD in Sweden. Pharmacoecon. Outcomes News 376, 7 (2002). https://doi.org/10.1007/BF03279478
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03279478